Kallingal A - Search Results

1

Identification of sustainable trypsin active-site inhibitors from Nigrospora sphaerica strain AVA-1.

Kallingal A, Thachan Kundil V, Ayyolath A, Muringayil Joseph T, Kar Mahapatra D, Haponiuk JT, Variyar EJ. Kallingal A, et al. J Basic Microbiol. 2021 Aug;61(8):709-720. doi: 10.1002/jobm.202100221. Epub 2021 Jul 6. J Basic Microbiol. 2021. PMID: 34228389

2

Molecular modeling study of tectoquinone and acteoside from Tectona grandis linn: a new SARS-CoV-2 main protease inhibitor against COVID-19.

Kallingal A, Thachan Kundil V, Ayyolath A, Karlapudi AP, Muringayil Joseph T, E JV. Kallingal A, et al. J Biomol Struct Dyn. 2022 Mar;40(4):1764-1775. doi: 10.1080/07391102.2020.1832580. Epub 2020 Oct 9. J Biomol Struct Dyn. 2022. PMID: 33036548

3

Extraction and optimization of Penicillium sclerotiorum strain AK-1 pigment for fabric dyeing.

Kallingal A, Ayyolath A, Thachan Kundil V, Joseph TM, Chandra D N, Haponiuk JT, Thomas S, Variyar E J. Kallingal A, et al. J Basic Microbiol. 2021 Oct;61(10):900-909. doi: 10.1002/jobm.202100349. Epub 2021 Aug 31. J Basic Microbiol. 2021. PMID: 34467566

4

Divulging the anti-acetylcholinesterase activity of Colletotrichum lentis strain KU1 extract as sustainable AChE active site inhibitors.

Kallingal A, Ayyolath A, Thachan Kundil V, Maniyeri Suresh A, Muringayil Joseph T, Haponiuk J, Thomas S, Augustine A. Kallingal A, et al. Arch Microbiol. 2022 Nov 17;204(12):713. doi: 10.1007/s00203-022-03288-9. Arch Microbiol. 2022. PMID: 36396887

5

3D printing of polylactic acid: recent advances and opportunities.

Joseph TM, Kallingal A, Suresh AM, Mahapatra DK, Hasanin MS, Haponiuk J, Thomas S. Joseph TM, et al. Among authors: kallingal a. Int J Adv Manuf Technol. 2023;125(3-4):1015-1035. doi: 10.1007/s00170-022-10795-y. Epub 2023 Jan 7. Int J Adv Manuf Technol. 2023. PMID: 36644783 Free PMC article. Review.

6

Investigating the disease-modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition.

Ayyolath A, Kallingal A, Kundil VT, Suresh AM, Jayadevi Variyar E. Ayyolath A, et al. Among authors: kallingal a. Chem Biol Drug Des. 2023 Aug;102(2):292-302. doi: 10.1111/cbdd.14244. Epub 2023 Apr 19. Chem Biol Drug Des. 2023. PMID: 37076430

7

Cancer immune escape: the role of antigen presentation machinery.

Kallingal A, Olszewski M, Maciejewska N, Brankiewicz W, Baginski M. Kallingal A, et al. J Cancer Res Clin Oncol. 2023 Aug;149(10):8131-8141. doi: 10.1007/s00432-023-04737-8. Epub 2023 Apr 9. J Cancer Res Clin Oncol. 2023. PMID: 37031434 Free PMC article. Review.

8

Synthesis and biological evaluation of novel 3,6- amide and thioamide substituted- 2,3,4,9-tetrahydro-1H-carbazoles for anti-cancer activity.

Trocka A, Kallingal A, Maciejewska N, Narajczyk M, Hromova A, Makowiec S. Trocka A, et al. Among authors: kallingal a. Eur J Med Chem. 2024 Nov 5;277:116755. doi: 10.1016/j.ejmech.2024.116755. Epub 2024 Aug 11. Eur J Med Chem. 2024. PMID: 39173283 Free article.

9

TRF1 and TRF2: pioneering targets in telomere-based cancer therapy.

Kallingal A, Krzemieniecki R, Maciejewska N, Brankiewicz-Kopcińska W, Baginski M. Kallingal A, et al. J Cancer Res Clin Oncol. 2024 Jul 16;150(7):353. doi: 10.1007/s00432-024-05867-3. J Cancer Res Clin Oncol. 2024. PMID: 39012375 Free PMC article. Review.

10

Targeting shelterin proteins for cancer therapy.

Brankiewicz-Kopcinska W, Kallingal A, Krzemieniecki R, Baginski M. Brankiewicz-Kopcinska W, et al. Among authors: kallingal a. Drug Discov Today. 2024 Aug;29(8):104056. doi: 10.1016/j.drudis.2024.104056. Epub 2024 Jun 4. Drug Discov Today. 2024. PMID: 38844065 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters